Thanks Katie,
Interesting, however I believe POH headhunted GC because of the benefit of his experience. POH is where Invion was a couple of years ago... Director / CEO defrauded shareholders, 2 drugs ready for phase 2 trials, have money in the bank...
POH employed GC for his expertise needed when dealing with US regulators over clinical trial design IMO.
IVX Price at posting:
3.3¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)